Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice

Lalani, Salima and Tan, Soon Hao and Tan, Kuan Onn * and Lim, Hui Xuan * and Ong, Kien Chai and Wong, Kum Thong and Poh, Chit Laa * (2021) Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice. Life Sciences, 287. p. 120097. ISSN 0024-3205

Full text not available from this repository. (Request a copy)
Official URL: http://doi.org/10.1016/j.lfs.2021.120097

Abstract

Aims: Enterovirus A71 (EV-A71) is an etiological agent of hand foot and mouth disease (HFMD) and has the potential to cause severe neurological infections in children. L-SP40 peptide was previously known to inhibit EV-A71 by prophylactic action. This study aimed to identify the mechanism of inhibition in Rhabdomyosarcoma (RD) cells and in vivo therapeutic potential of L-SP40 peptide in a murine model. Main methods: A pull-down assay was performed to identify the binding partner of the L-SP40 peptide. Co-immunoprecipitation and co-localization assays with the L-SP40 peptide were employed to confirm the receptor partner in RD cells. The outcomes were validated using receptor knockdown and antibody blocking assays. The L-SP40 peptide was further evaluated for the protection of neonatal mice against lethal challenge by mouse-adapted EV-A71. Key findings: The L-SP40 peptide was found to interact and co-localize with nucleolin, the key attachment receptor of Enteroviruses A species, as demonstrated in the pull-down, co-immunoprecipitation and co-localization assays. Knockdown of nucleolin from RD cells led to a significant reduction of 3.5 logs of viral titer of EV-A71. The L-SP40 peptide demonstrated 80% protection of neonatal mice against lethal challenge by the mouse-adapted virus with a drastic reduction in the viral loads in the blood (~4.5 logs), skeletal muscles (1.5 logs) and brain stem (1.5 logs). Significance: L-SP40 peptide prevented severe hind limb paralysis and death in suckling mice and could serve as a potential broad-spectrum antiviral candidate to be further evaluated for safety and potency in future clinical trials against EV-A71

Item Type: Article
Uncontrolled Keywords: Enterovirus A71 (EV-A71); Hand, foot and mouth disease (HFMD); Antiviral; In vivo protection; Nucleolin; L-SP40 peptide
Subjects: Q Science > QR Microbiology > QR355 Virology
Divisions: Others > Non Sunway Academics
Sunway University > School of Medical and Life Sciences [formerly School of Healthcare and Medical Sciences until 2020] > Centre for Virus and Vaccine Research
Sunway University > School of Medical and Life Sciences [formerly School of Healthcare and Medical Sciences until 2020] > Dept. Biological Sciences
Depositing User: Dr Janaki Sinnasamy
Related URLs:
Date Deposited: 06 Dec 2021 02:31
Last Modified: 06 Dec 2021 02:42
URI: http://eprints.sunway.edu.my/id/eprint/1880

Actions (login required)

View Item View Item